Dr. Ingo Lämmermann – post-doc with 7 years of experience in aging research, who formed the hypothesis on which this project is based on. Inventor of two patents, of which one is already translated into a product.

Assoc. Prof. Johannes Grillari – Head of the LBI for trauma and regeneration and the CD Laboratory for the Biotechnology of Skin Aging; Co-founder of TAmiRNA and Evercyte; 14 patents filed; > 130 peer-reviewed articles

Otto Kanzler – CEO of Chorus, Evercyte, Syconium, InnoFly Management; CFO of TAmiRNA, Phoenestra; from 1981 - 2007 department head at Boehringer Ingelheim Austria.